Target Name: TMPRSS11A
NCBI ID: G339967
Review Report on TMPRSS11A Target / Biomarker Content of Review Report on TMPRSS11A Target / Biomarker
TMPRSS11A
Other Name(s): Transmembrane protease serine 11A (isoform 2) | Transmembrane serine protease 11A, transcript variant 1 | Transmembrane serine protease 11A, transcript variant 2 | transmembrane serine protease 11A | airway trypsin-like protease 1 | HESP | Esophageal cancer-susceptibility gene 1 protein | MGC133183 | Epidermal type-II transmembrane serine protease | transmembrane protease, serine 11A | TM11A_HUMAN | ECRG1 | Epidermal type II transmembrane serine protease | Transmembrane protease serine 11A (isoform 1) | HATL1 | esophageal cancer-susceptibility gene 1 protein | Transmembrane protease serine 11A | Airway trypsin-like protease 1 | epidermal type-II transmembrane serine protease

Understanding TMPRSS11A: A Potential Drug Target and Biomarker

TMPRSS11A (Transmembrane protease serine 11A (isoform 2)) is a protein that is expressed in a variety of tissues throughout the body, including the brain, heart, kidneys, and intestine. It is a member of the superfamily of transmembrane proteases, which are enzymes that span the membrane of a cell and extend into the cytoplasm. This protein is known to be involved in the regulation of a variety of cellular processes, including cell signaling, neurotransmitter clearance, and inflammation.

TMPRSS11A is a potential drug target for a variety of therapeutic applications. Its involvement in neurotransmitter clearance makes it a promising target for treatments of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and depression. The protein is also involved in the regulation of cell signaling, which makes it a potential target for treatments of a variety of diseases, including cancer, including neuroendocrine tumors.

TMPRSS11A is also a potential biomarker for a variety of diseases. Its expression has been detected in a variety of tissues and has been associated with a number of diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. The protein is also expressed in the blood, which makes it a potential marker for disease risk and disease progression.

One of the challenges in studying TMPRSS11A is its expression and function. Because it is a protein that is expressed in a variety of tissues, it is difficult to study its function in any specific cell or tissue. Additionally, the structure and function of TMPRSS11A are not well understood, which can make it difficult to predict its effects as a drug or biomarker.

Despite these challenges, research into TMPRSS11A is ongoing. Researchers are studying its expression and function in a variety of organisms, including mammals, with the goal of understanding its role in cellular processes and its potential as a drug or biomarker.

In conclusion, TMPRSS11A is a protein that is expressed in a variety of tissues throughout the body and is involved in a number of cellular processes. Its potential as a drug target and biomarker makes it a promising target for a variety of therapeutic applications. Further research is needed to fully understand its role in cellular processes and its potential as a therapeutic agent.

Protein Name: Transmembrane Serine Protease 11A

Functions: Probable serine protease which may play a role in cellular senescence. Overexpression inhibits cell growth and induce G1 cell cycle arrest

The "TMPRSS11A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMPRSS11A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TMPRSS11B | TMPRSS11BNL | TMPRSS11D | TMPRSS11E | TMPRSS11F | TMPRSS12 | TMPRSS13 | TMPRSS15 | TMPRSS2 | TMPRSS3 | TMPRSS4 | TMPRSS5 | TMPRSS6 | TMPRSS7 | TMPRSS9 | TMSB10 | TMSB15A | TMSB15B | TMSB4X | TMSB4XP1 | TMSB4XP2 | TMSB4XP4 | TMSB4XP8 | TMSB4Y | TMTC1 | TMTC2 | TMTC3 | TMTC4 | TMUB1 | TMUB2 | TMX1 | TMX2 | TMX2-CTNND1 | TMX3 | TMX4 | TNC | TNF | TNF receptor-associated factor (TRAF) | TNFAIP1 | TNFAIP2 | TNFAIP3 | TNFAIP6 | TNFAIP8 | TNFAIP8L1 | TNFAIP8L2 | TNFAIP8L2-SCNM1 | TNFAIP8L3 | TNFRSF10A | TNFRSF10A-DT | TNFRSF10B | TNFRSF10C | TNFRSF10D | TNFRSF11A | TNFRSF11B | TNFRSF12A | TNFRSF13B | TNFRSF13C | TNFRSF14 | TNFRSF14-AS1 | TNFRSF17 | TNFRSF18 | TNFRSF19 | TNFRSF1A | TNFRSF1B | TNFRSF21 | TNFRSF25 | TNFRSF4 | TNFRSF6B | TNFRSF8 | TNFRSF9 | TNFSF10 | TNFSF11 | TNFSF12 | TNFSF12-TNFSF13 | TNFSF13 | TNFSF13B | TNFSF14 | TNFSF15 | TNFSF18 | TNFSF4 | TNFSF8 | TNFSF9 | TNIK | TNIP1 | TNIP2 | TNIP2P1 | TNIP3 | TNK1 | TNK2 | TNK2-AS1 | TNKS | TNKS1BP1 | TNKS2 | TNMD | TNN | TNNC1 | TNNI1 | TNNI2 | TNNI3 | TNNI3K